Metagenomi Therapeutics Quick Ratio 2022-2026 | MGX
Historical quick ratio values for Metagenomi Therapeutics (MGX) over the last 10 years.
| Metagenomi Therapeutics Quick Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets - Inventory | Current Liabilities | Quick Ratio |
| 2026-03-31 | $0.00B | $0.02B | 0.00 |
| 2025-12-31 | $0.00B | $0.02B | 0.00 |
| 2025-09-30 | $0.00B | $0.03B | 0.00 |
| 2025-06-30 | $0.00B | $0.03B | 0.00 |
| 2025-03-31 | $0.00B | $0.04B | 0.00 |
| 2024-12-31 | $0.00B | $0.04B | 0.00 |
| 2024-09-30 | $0.00B | $0.05B | 0.00 |
| 2024-06-30 | $0.00B | $0.05B | 0.00 |
| 2024-03-31 | $0.00B | $0.07B | 0.00 |
| 2023-12-31 | $0.00B | $0.07B | 0.00 |
| 2023-09-30 | $0.00B | 0.00 | |
| 2023-06-30 | $0.00B | 0.00 | |
| 2023-03-31 | $0.00B | 0.00 | |
| 2022-12-31 | $0.00B | $0.05B | 0.00 |
| 2021-12-31 | $0.00B | $0.03B | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $0.052B | $0.025B |
| Metagenomi Therapeutics Inc. is an in vivo genome editing company capitalizing on its proprietary technologies to create curative genetic medicines for patients. Metagenomi Therapeutics Inc., formerly known as Metagenomi Inc., is based in EMERYVILLE, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $35.437B | 10.97 |
| BridgeBio Pharma (BBIO) | United States | $14.460B | 0.00 |
| Dr Reddy's Laboratories (RDY) | India | $11.109B | 17.29 |
| Aspen Pharmacare (APNHY) | South Africa | $3.708B | 0.00 |
| Supernus Pharmaceuticals (SUPN) | United States | $2.918B | 22.33 |
| Bausch Health Cos (BHC) | Canada | $2.086B | 1.50 |
| Taysha Gene Therapies (TSHA) | United States | $1.290B | 0.00 |
| Amphastar Pharmaceuticals (AMPH) | United States | $0.924B | 7.28 |
| Personalis (PSNL) | United States | $0.630B | 0.00 |
| Assembly Biosciences (ASMB) | United States | $0.451B | 0.00 |
| Sol-Gel Technologies (SLGL) | Israel | $0.210B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.019B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |